Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy

CF Rose, P Amodio, JS Bajaj, RK Dhiman… - Journal of …, 2020 - Elsevier
Hepatic encephalopathy (HE) is a frequent and serious complication of both chronic liver
disease and acute liver failure. HE manifests as a wide spectrum of neuropsychiatric …

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

M Cornberg, M Buti, CS Eberhardt, PA Grossi… - Journal of …, 2021 - Elsevier
According to a recent World Health Organization estimate, the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic, which originated in China in 2019, has …

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

P Angeli, M Bernardi, C Villanueva, C Francoz… - Journal of …, 2018 - Elsevier
The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …

Liver cirrhosis

P Ginès, A Krag, JG Abraldes, E Solà, N Fabrellas… - The Lancet, 2021 - thelancet.com
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such
as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C …

EASL Clinical Practice Guidelines: Management of alcohol-related liver disease

M Thursz, A Gual, C Lackner, P Mathurin, C Moreno… - Journal of …, 2018 - Elsevier
The harmful use of alcohol has been estimated to cause approximately 3.3 million deaths
every year, corresponding to nearly 6% of all deaths globally. Therefore, the effective …

Liver macrophages in tissue homeostasis and disease

O Krenkel, F Tacke - Nature Reviews Immunology, 2017 - nature.com
Macrophages represent a key cellular component of the liver, and are essential for
maintaining tissue homeostasis and ensuring rapid responses to hepatic injury. Our …

Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide

S Piano, V Singh, P Caraceni, R Maiwall… - Gastroenterology, 2019 - Elsevier
Background & Aims Bacterial infections are common and life-threatening in patients with
cirrhosis. Little is known about the epidemiology of bacterial infections in different regions …

Targeting hepatic macrophages to treat liver diseases

F Tacke - Journal of hepatology, 2017 - Elsevier
Our view on liver macrophages in the context of health and disease has been reformed by
the recognition of a remarkable heterogeneity of phagocytes in the liver. Liver macrophages …

The gut microbiome and liver cancer: mechanisms and clinical translation

LX Yu, RF Schwabe - Nature reviews Gastroenterology & hepatology, 2017 - nature.com
Hepatocellular carcinoma (HCC) is the third leading cause of worldwide cancer mortality.
HCC almost exclusively develops in patients with chronic liver disease, driven by a vicious …

Towards a new definition of decompensated cirrhosis

G D'Amico, M Bernardi, P Angeli - Journal of hepatology, 2022 - Elsevier
There is a universal agreement that the occurrence of clinical complications, such as ascites,
hepatic encephalopathy, gastrointestinal bleeding, and jaundice mark the transition from the …